CRISPR Therapeutics AG (CRSP) Share-based Compensation (2015 - 2026)
CRISPR Therapeutics AG's Share-based Compensation was $17.32 million in Q2 2026, down 1.7% from $17.61 million a year earlier but up 6.1% from the prior quarter.
Powered by 
Analysis
CRISPR Therapeutics AG (CRSP) Share-based Compensation (2015 - 2026) Analysis & Trends
On a trailing twelve-month basis, CRISPR Therapeutics AG's Share-based Compensation was $68.32 million through Jun 30, 2026, down 16.0% year-over-year; for FY2025, it came in at $72.5 million, down 16.3% from FY2024.
- Share-based Compensation shows a five-year compound annual growth rate of 1.9% (FY2020 to FY2025).
- In earlier years, Share-based Compensation was $86.57 million in FY2024 (+6.8%), $81.03 million in FY2023 (-17.3%), $97.95 million in FY2022 (-4.3%) and $102.39 million in FY2021 (+55.1%).
- Quarterly Share-based Compensation has moved between $16.32 million (Q1 2026) and $26.2 million (Q3 2021) over five years.
- Compared with a year earlier, Share-based Compensation has declined for five straight quarters, with an average decline of 7.0% over the last eight quarters.
- The best year-over-year quarter for Share-based Compensation over five years was Q3 2021 (growth of 52.0%); the worst was Q2 2025 (a decline of 25.6%).
- Per Business Quant data, CRSP's Share-based Compensation in the three quarters before Q2 2026 was $16.32 million (Q1 2026), $18.08 million (Q4 2025) and $16.6 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | CRISPR Therapeutics AG | 5.23 Bn | 5.23 Bn | - | 17.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.32 Mn |
| Mar 31, 2026 | 16.32 Mn |
| Dec 31, 2025 | 18.08 Mn |
| Sep 30, 2025 | 16.60 Mn |
| Jun 30, 2025 | 17.61 Mn |
| Mar 31, 2025 | 20.21 Mn |
| Dec 31, 2024 | 21.95 Mn |
| Sep 30, 2024 | 21.54 Mn |
| Jun 30, 2024 | 23.67 Mn |
| Mar 31, 2024 | 19.41 Mn |
| Dec 31, 2023 | 18.42 Mn |
| Sep 30, 2023 | 19.97 Mn |
| Jun 30, 2023 | 21.77 Mn |
| Mar 31, 2023 | 20.88 Mn |
| Dec 31, 2022 | 22.81 Mn |
| Sep 30, 2022 | 24.55 Mn |
| Jun 30, 2022 | 24.85 Mn |
| Mar 31, 2022 | 25.75 Mn |
| Dec 31, 2021 | 25.77 Mn |
| Sep 30, 2021 | 26.20 Mn |
API Access
CRISPR Therapeutics AG Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CRSP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "CRSP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CRSP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();